Index by author
February 01, 1995; Volume 272,Issue 2
A
Adachi, H
- You have accessA selective type V phosphodiesterase inhibitor, E4021, dilates porcine large coronary artery.T Saeki, H Adachi, Y Takase, S Yoshitake, S Souda and I SaitoJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 825-831;
Adrien, J
- You have accessAre postsynaptic 5-HT1A receptors involved in the anxiolytic effects of 5-HT1A receptor agonists and in their inhibitory effects on the firing of serotonergic neurons in the rat?T Jolas, R Schreiber, A M Laporte, M Chastanet, J De Vry, T Glaser, J Adrien and M HamonJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 920-929;
Aguilar, H
- You have accessUrsodeoxycholate (UDCA) inhibits the mitochondrial membrane permeability transition induced by glycochenodeoxycholate: a mechanism of UDCA cytoprotection.R Botla, J R Spivey, H Aguilar, S F Bronk and G J GoresJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 930-938;
Albrightson, C R
- You have accessSeparation of immunomodulatory and cholesterol-lowering activities of heterocyclic azaspiranes.C R Albrightson, P J Bugelski, T A Berkhout, B Jackson, W D Kerns, A J Organ and A M BadgerJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 689-698;
Alling, D W
- You have accessTherapeutic trial of reconstituted human high-density lipoprotein in a canine model of gram-negative septic shock.Z M Quezado, C Natanson, S M Banks, D W Alling, C A Koev, R L Danner, R J Elin, J M Hosseini, T S Parker and D M LevineJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 604-611;
Alvarez, I
- You have accessSome novel 5-hydroxytryptamine1A (5-HT1A) receptor agonists reduce gastric acid and pepsin secretion, reduce experimental gastric mucosal injury and enhance gastric mucus in rats.A J Farré, M Colombo, I Alvarez and G B GlavinJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 832-837;
Andersson, R G
- You have accessPertussis toxin attenuates presynaptic inhibition of cholinergic but not nonadrenergic noncholinergic contraction in guinea pig airways.I G Johansson-Rydberg, N Grundström and R G AnderssonJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 786-790;
Apparsundaram, S
- You have accessRole of prejunctional beta adrenoceptors in rat cardiac sympathetic neurotransmission.S Apparsundaram and D C EikenburgJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 519-526;
Atchison, W D
- You have accessThe paralytic agent 2,4-dithiobiuret decreases open time of murine skeletal muscle acetylcholine receptor channels.J M Spitsbergen and W D AtchisonJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 645-651;
Awazu, S
- You have accessAbsorption-enhancing mechanism of sodium caprate and decanoylcarnitine in Caco-2 cells.M Tomita, M Hayashi and S AwazuJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 739-743;
Azorlosa, J L
- You have accessMarijuana smoking: effects of varying puff volume and breathhold duration.J L Azorlosa, M K Greenwald and M L StitzerJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 560-569;
B
Badger, A M
- You have accessSeparation of immunomodulatory and cholesterol-lowering activities of heterocyclic azaspiranes.C R Albrightson, P J Bugelski, T A Berkhout, B Jackson, W D Kerns, A J Organ and A M BadgerJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 689-698;
Banks, S M
- You have accessTherapeutic trial of reconstituted human high-density lipoprotein in a canine model of gram-negative septic shock.Z M Quezado, C Natanson, S M Banks, D W Alling, C A Koev, R L Danner, R J Elin, J M Hosseini, T S Parker and D M LevineJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 604-611;
Barg, J
- You have accessLow doses of anandamides inhibit pharmacological effects of delta 9-tetrahydrocannabinol.E Fride, J Barg, R Levy, D Saya, E Heldman, R Mechoulam and Z VogelJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 699-707;
Beauchamp, H T
- You have accessIn vivo receptor occupancy of the angiotensin II receptor by nonpeptide antagonists: relationship to in vitro affinities and in vivo pharmacologic potency.H T Beauchamp, R S Chang, P K Siegl and R E GibsonJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 612-618;
Bédard, P J
- You have accessContinuous administration decreases and pulsatile administration increases behavioral sensitivity to a novel dopamine D2 agonist (U-91356A) in MPTP-exposed monkeys.P J Blanchet, F Calon, J C Martel, P J Bédard, T Di Paolo, R R Walters and M F PierceyJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 854-859;
Bell, R L
- You have accessOptimization of the potency and duration of action of N-hydroxyurea 5-lipoxygenase inhibitors.R L Bell, J B Bouska, P E Malo, C Lanni, R R Harris, E R Otis, A O Stewart, D W Brooks and G W CarterJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 724-731;
Bemis, K G
- You have accessIn vivo effects of a novel thromboxane A2/prostaglandin H2 (TXA2/PGH2) partial agonist, (+)5(Z)-7-[3-endo-phenylsulfonylamino[2.2.1]- bicyclohept-2-exo-yl]-heptenoic acid [(+)-S-145], on vascular, platelet and cardiac function.G P Dubé, J A Jakubowski, K A Brune, K G Bemis and W L KurtzJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 799-807;
Berkhout, T A
- You have accessSeparation of immunomodulatory and cholesterol-lowering activities of heterocyclic azaspiranes.C R Albrightson, P J Bugelski, T A Berkhout, B Jackson, W D Kerns, A J Organ and A M BadgerJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 689-698;
Bigelow, G E
- You have accessBuprenorphine effects in methadone-maintained volunteers: effects at two hours after methadone.E C Strain, K L Preston, I A Liebson and G E BigelowJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 628-638;
Blanchet, P J
- You have accessContinuous administration decreases and pulsatile administration increases behavioral sensitivity to a novel dopamine D2 agonist (U-91356A) in MPTP-exposed monkeys.P J Blanchet, F Calon, J C Martel, P J Bédard, T Di Paolo, R R Walters and M F PierceyJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 854-859;
Bloom, F E
- You have accessInterleukin-2 (IL-2) induces corticotropin-releasing factor (CRF) release from the amygdala and involves a nitric oxide-mediated signaling; comparison with the hypothalamic response.J Raber, G F Koob and F E BloomJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 815-824;
Bonkovsky, H L
- You have accessTissue distribution of zinc-mesoporphyrin in rats: relationship to inhibition of heme oxygenase.S M Russo, J A Pepe, S Donohue, E E Cable, R W Lambrecht and H L BonkovskyJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 766-774;
Botla, R
- You have accessUrsodeoxycholate (UDCA) inhibits the mitochondrial membrane permeability transition induced by glycochenodeoxycholate: a mechanism of UDCA cytoprotection.R Botla, J R Spivey, H Aguilar, S F Bronk and G J GoresJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 930-938;
Boulanger, C M
- You have accessPrevious exposure to bradykinin unmasks an endothelium-dependent relaxation to the converting enzyme inhibitor trandolaprilat in isolated canine coronary arteries.B Desta, M Nakashima, M Kirchengast, P M Vanhoutte and C M BoulangerJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 885-891;
Bouska, J B
- You have accessOptimization of the potency and duration of action of N-hydroxyurea 5-lipoxygenase inhibitors.R L Bell, J B Bouska, P E Malo, C Lanni, R R Harris, E R Otis, A O Stewart, D W Brooks and G W CarterJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 724-731;
Bridal, T R
- You have accessVoltage-dependent inhibition of the ATP-sensitive K+ current by the class Ia agent disopyramide in cat ventricular myocytes.F G de Lorenzi, T R Bridal and W SpinelliJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 714-723;
Bronk, S F
- You have accessUrsodeoxycholate (UDCA) inhibits the mitochondrial membrane permeability transition induced by glycochenodeoxycholate: a mechanism of UDCA cytoprotection.R Botla, J R Spivey, H Aguilar, S F Bronk and G J GoresJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 930-938;
Brooks, D W
- You have accessOptimization of the potency and duration of action of N-hydroxyurea 5-lipoxygenase inhibitors.R L Bell, J B Bouska, P E Malo, C Lanni, R R Harris, E R Otis, A O Stewart, D W Brooks and G W CarterJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 724-731;
Brune, K A
- You have accessIn vivo effects of a novel thromboxane A2/prostaglandin H2 (TXA2/PGH2) partial agonist, (+)5(Z)-7-[3-endo-phenylsulfonylamino[2.2.1]- bicyclohept-2-exo-yl]-heptenoic acid [(+)-S-145], on vascular, platelet and cardiac function.G P Dubé, J A Jakubowski, K A Brune, K G Bemis and W L KurtzJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 799-807;
Bugelski, P J
- You have accessSeparation of immunomodulatory and cholesterol-lowering activities of heterocyclic azaspiranes.C R Albrightson, P J Bugelski, T A Berkhout, B Jackson, W D Kerns, A J Organ and A M BadgerJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 689-698;
Butelman, E R
- You have accessButorphanol: characterization of agonist and antagonist effects in rhesus monkeys.E R Butelman, G Winger, G Zernig and J H WoodsJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 845-853;
Butler, A M
- You have accessIdentification of a reversible component in the in vitro inhibition of rat hepatic cytochrome P450 2B1 by parathion.M Murray and A M ButlerJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 639-644;
C
Cable, E E
- You have accessTissue distribution of zinc-mesoporphyrin in rats: relationship to inhibition of heme oxygenase.S M Russo, J A Pepe, S Donohue, E E Cable, R W Lambrecht and H L BonkovskyJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 766-774;
Calon, F
- You have accessContinuous administration decreases and pulsatile administration increases behavioral sensitivity to a novel dopamine D2 agonist (U-91356A) in MPTP-exposed monkeys.P J Blanchet, F Calon, J C Martel, P J Bédard, T Di Paolo, R R Walters and M F PierceyJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 854-859;
Campos, H A
- You have accessInteraction between noradrenergic and histamine-containing neurons in the rat vas deferens.H A Campos and J DomínguezJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 732-738;
Carpéné, C
- You have accessInhibition of amine oxidase activity by derivatives that recognize imidazoline I2 sites.C Carpéné, P Collon, A Remaury, A Cordi, A Hudson, D Nutt and M LafontanJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 681-688;
Carter, D B
- You have access[4-Dimethyl-3-t-butylcarboxyl-4,5-dihydro (1,5-a) quinoxaline] is a novel ligand to the picrotoxin site on GABAA receptors, and decreases single-channel open probability.G H Dillon, W B Im, J F Pregenzer, D B Carter and B J HamiltonJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 597-603;
Carter, G W
- You have accessOptimization of the potency and duration of action of N-hydroxyurea 5-lipoxygenase inhibitors.R L Bell, J B Bouska, P E Malo, C Lanni, R R Harris, E R Otis, A O Stewart, D W Brooks and G W CarterJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 724-731;
Chang, R S
- You have accessIn vivo receptor occupancy of the angiotensin II receptor by nonpeptide antagonists: relationship to in vitro affinities and in vivo pharmacologic potency.H T Beauchamp, R S Chang, P K Siegl and R E GibsonJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 612-618;
Chastanet, M
- You have accessAre postsynaptic 5-HT1A receptors involved in the anxiolytic effects of 5-HT1A receptor agonists and in their inhibitory effects on the firing of serotonergic neurons in the rat?T Jolas, R Schreiber, A M Laporte, M Chastanet, J De Vry, T Glaser, J Adrien and M HamonJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 920-929;
Chiba, S
- You have accessSelective inhibition by zatebradine and discrete parasympathetic stimulation of the positive chronotropic response to sympathetic stimulation in anesthetized dogs.Y Furukawa, H Nakano, T Oguchi, M Kasama, Y Hoyano and S ChibaJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 744-749;
- You have accessAre negative chronotropic and inotropic responses to adenosine differentiated at the receptor or postreceptor levels in isolated dog hearts?T Oguchi, Y Furukawa, S Sawaki, M Kasama and S ChibaJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 838-844;
Chikkala, D N
- You have accessComparison of the properties of agmatine and endogenous clonidine-displacing substance at imidazoline and alpha-2 adrenergic receptors.J E Piletz, D N Chikkala and P ErnsbergerJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 581-587;
Childers, S R
- You have accessBehavioral and local cerebral metabolic effects of the novel tropane analog, 2 beta-propanoyl-3 beta-(4-tolyl)-tropane.L J Porrino, H M Davies and S R ChildersJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 901-910;
Collon, P
- You have accessInhibition of amine oxidase activity by derivatives that recognize imidazoline I2 sites.C Carpéné, P Collon, A Remaury, A Cordi, A Hudson, D Nutt and M LafontanJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 681-688;
Colombo, M
- You have accessSome novel 5-hydroxytryptamine1A (5-HT1A) receptor agonists reduce gastric acid and pepsin secretion, reduce experimental gastric mucosal injury and enhance gastric mucus in rats.A J Farré, M Colombo, I Alvarez and G B GlavinJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 832-837;
Cordi, A
- You have accessInhibition of amine oxidase activity by derivatives that recognize imidazoline I2 sites.C Carpéné, P Collon, A Remaury, A Cordi, A Hudson, D Nutt and M LafontanJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 681-688;
Cuello, A C
- You have accessPharmacological characterization of nerve growth factor and/or monosialoganglioside GM1 effects on cholinergic markers in the adult lesioned brain.L Garofalo and A C CuelloJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 527-545;
D
Danner, R L
- You have accessTherapeutic trial of reconstituted human high-density lipoprotein in a canine model of gram-negative septic shock.Z M Quezado, C Natanson, S M Banks, D W Alling, C A Koev, R L Danner, R J Elin, J M Hosseini, T S Parker and D M LevineJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 604-611;
Dantzler, W H
- You have accessKinetics of interactions of para-aminohippurate, probenecid, cysteine conjugates and N-acetyl cysteine conjugates with basolateral organic anion transporter in isolated rabbit proximal renal tubules.W H Dantzler, K K Evans and S H WrightJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 663-672;
Davies, H M
- You have accessBehavioral and local cerebral metabolic effects of the novel tropane analog, 2 beta-propanoyl-3 beta-(4-tolyl)-tropane.L J Porrino, H M Davies and S R ChildersJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 901-910;
de Lorenzi, F G
- You have accessVoltage-dependent inhibition of the ATP-sensitive K+ current by the class Ia agent disopyramide in cat ventricular myocytes.F G de Lorenzi, T R Bridal and W SpinelliJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 714-723;
Desforges, B
- You have accessEffects of morphine on the pathogenesis of murine Friend retrovirus infection.M L Veyries, M Sinet, B Desforges and B RouveixJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 498-504;
Desta, B
- You have accessPrevious exposure to bradykinin unmasks an endothelium-dependent relaxation to the converting enzyme inhibitor trandolaprilat in isolated canine coronary arteries.B Desta, M Nakashima, M Kirchengast, P M Vanhoutte and C M BoulangerJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 885-891;
De Vry, J
- You have accessAre postsynaptic 5-HT1A receptors involved in the anxiolytic effects of 5-HT1A receptor agonists and in their inhibitory effects on the firing of serotonergic neurons in the rat?T Jolas, R Schreiber, A M Laporte, M Chastanet, J De Vry, T Glaser, J Adrien and M HamonJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 920-929;
Diana, M
- You have accessProfound decrease of mesolimbic dopaminergic neuronal activity in morphine withdrawn rats.M Diana, M Pistis, A Muntoni and G GessaJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 781-785;
Dillon, G H
- You have access[4-Dimethyl-3-t-butylcarboxyl-4,5-dihydro (1,5-a) quinoxaline] is a novel ligand to the picrotoxin site on GABAA receptors, and decreases single-channel open probability.G H Dillon, W B Im, J F Pregenzer, D B Carter and B J HamiltonJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 597-603;
Di Paolo, T
- You have accessContinuous administration decreases and pulsatile administration increases behavioral sensitivity to a novel dopamine D2 agonist (U-91356A) in MPTP-exposed monkeys.P J Blanchet, F Calon, J C Martel, P J Bédard, T Di Paolo, R R Walters and M F PierceyJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 854-859;
Domínguez, J
- You have accessInteraction between noradrenergic and histamine-containing neurons in the rat vas deferens.H A Campos and J DomínguezJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 732-738;
Donohue, S
- You have accessTissue distribution of zinc-mesoporphyrin in rats: relationship to inhibition of heme oxygenase.S M Russo, J A Pepe, S Donohue, E E Cable, R W Lambrecht and H L BonkovskyJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 766-774;
Drew, G M
- You have accessPharmacological effects of GR138950, a novel angiotensin AT1 receptor antagonist.A Hilditch, A A Hunt, A Travers, J Polley, G M Drew, D Middlemiss, D B Judd, B C Ross and M J RobertsonJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 750-757;
Dubé, G P
- You have accessIn vivo effects of a novel thromboxane A2/prostaglandin H2 (TXA2/PGH2) partial agonist, (+)5(Z)-7-[3-endo-phenylsulfonylamino[2.2.1]- bicyclohept-2-exo-yl]-heptenoic acid [(+)-S-145], on vascular, platelet and cardiac function.G P Dubé, J A Jakubowski, K A Brune, K G Bemis and W L KurtzJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 799-807;
Dumont, Y
- You have accessCharacterization of neuropeptide Y binding sites in rat brain membrane preparations using [125I][Leu31,Pro34]peptide YY and [125I]peptide YY3-36 as selective Y1 and Y2 radioligands.Y Dumont, A Fournier, S St-Pierre and R QuirionJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 673-680;
Dykstra, L A
- You have accessMechanisms whereby macrophage-derived nitric oxide is involved in morphine-induced suppression of splenic lymphocyte proliferation.K Fecho, K A Maslonek, L A Dykstra and D T LysleJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 477-483;
E
Eikenburg, D C
- You have accessRole of prejunctional beta adrenoceptors in rat cardiac sympathetic neurotransmission.S Apparsundaram and D C EikenburgJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 519-526;
Elin, R J
- You have accessTherapeutic trial of reconstituted human high-density lipoprotein in a canine model of gram-negative septic shock.Z M Quezado, C Natanson, S M Banks, D W Alling, C A Koev, R L Danner, R J Elin, J M Hosseini, T S Parker and D M LevineJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 604-611;
Ernsberger, P
- You have accessComparison of the properties of agmatine and endogenous clonidine-displacing substance at imidazoline and alpha-2 adrenergic receptors.J E Piletz, D N Chikkala and P ErnsbergerJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 581-587;
Evans, K K
- You have accessKinetics of interactions of para-aminohippurate, probenecid, cysteine conjugates and N-acetyl cysteine conjugates with basolateral organic anion transporter in isolated rabbit proximal renal tubules.W H Dantzler, K K Evans and S H WrightJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 663-672;
F
Faiman, M D
- You have accessCharacterization of diethyldithiocarbamate methyl ester sulfine as an intermediate in the bioactivation of disulfiram.A Madan and M D FaimanJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 775-780;
Farfel, G M
- You have accessRole of hypothermia in the mechanism of protection against serotonergic toxicity. I. Experiments using 3,4-methylenedioxymethamphetamine, dizocilpine, CGS 19755 and NBQX.G M Farfel and L S SeidenJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 860-867;
- You have accessRole of hypothermia in the mechanism of protection against serotonergic toxicity. II. Experiments with methamphetamine, p-chloroamphetamine, fenfluramine, dizocilpine and dextromethorphan.G M Farfel and L S SeidenJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 868-875;
Farré, A J
- You have accessSome novel 5-hydroxytryptamine1A (5-HT1A) receptor agonists reduce gastric acid and pepsin secretion, reduce experimental gastric mucosal injury and enhance gastric mucus in rats.A J Farré, M Colombo, I Alvarez and G B GlavinJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 832-837;
Fecho, K
- You have accessMechanisms whereby macrophage-derived nitric oxide is involved in morphine-induced suppression of splenic lymphocyte proliferation.K Fecho, K A Maslonek, L A Dykstra and D T LysleJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 477-483;
Finkel, M S
- You have accessNitric oxide synthase inhibitor alters papillary muscle force-frequency relationship.M S Finkel, C V Oddis, O H Mayer, B G Hattler and R L SimmonsJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 945-952;
Fournier, A
- You have accessCharacterization of neuropeptide Y binding sites in rat brain membrane preparations using [125I][Leu31,Pro34]peptide YY and [125I]peptide YY3-36 as selective Y1 and Y2 radioligands.Y Dumont, A Fournier, S St-Pierre and R QuirionJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 673-680;
Fox, M
- You have accessRepression of angiotensin II and potentiation of bradykinin contribute to the synergistic effects of dual metalloprotease inhibition in heart failure.N C Trippodo, B C Panchal and M FoxJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 619-627;
Fride, E
- You have accessLow doses of anandamides inhibit pharmacological effects of delta 9-tetrahydrocannabinol.E Fride, J Barg, R Levy, D Saya, E Heldman, R Mechoulam and Z VogelJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 699-707;
Fujita, T
- You have accessAquaretic effect of a potent, orally active, nonpeptide V2 antagonist in men.A Ohnishi, Y Orita, N Takagi, T Fujita, T Toyoki, Y Ihara, Y Yamamura, T Inoue and T TanakaJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 546-551;
Fukui, H
- You have accessMepyramine, a histamine H1 receptor antagonist, inhibits the metabolic activity of rat and human P450 2D forms.T Hiroi, N Ohishi, S Imaoka, Y Yabusaki, H Fukui and Y FunaeJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 939-944;
Funae, Y
- You have accessMepyramine, a histamine H1 receptor antagonist, inhibits the metabolic activity of rat and human P450 2D forms.T Hiroi, N Ohishi, S Imaoka, Y Yabusaki, H Fukui and Y FunaeJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 939-944;
Furukawa, Y
- You have accessSelective inhibition by zatebradine and discrete parasympathetic stimulation of the positive chronotropic response to sympathetic stimulation in anesthetized dogs.Y Furukawa, H Nakano, T Oguchi, M Kasama, Y Hoyano and S ChibaJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 744-749;
- You have accessAre negative chronotropic and inotropic responses to adenosine differentiated at the receptor or postreceptor levels in isolated dog hearts?T Oguchi, Y Furukawa, S Sawaki, M Kasama and S ChibaJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 838-844;
G
Garaulet, J V
- You have accessCross-tolerance between kappa and mu opioid agonists in the guinea pig ileum myenteric plexus.J V Garaulet, M V Milanés and M L LaordenJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 658-662;
Garofalo, L
- You have accessPharmacological characterization of nerve growth factor and/or monosialoganglioside GM1 effects on cholinergic markers in the adult lesioned brain.L Garofalo and A C CuelloJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 527-545;
Gessa, G
- You have accessProfound decrease of mesolimbic dopaminergic neuronal activity in morphine withdrawn rats.M Diana, M Pistis, A Muntoni and G GessaJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 781-785;
Gibson, R E
- You have accessIn vivo receptor occupancy of the angiotensin II receptor by nonpeptide antagonists: relationship to in vitro affinities and in vivo pharmacologic potency.H T Beauchamp, R S Chang, P K Siegl and R E GibsonJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 612-618;
Glaser, T
- You have accessAre postsynaptic 5-HT1A receptors involved in the anxiolytic effects of 5-HT1A receptor agonists and in their inhibitory effects on the firing of serotonergic neurons in the rat?T Jolas, R Schreiber, A M Laporte, M Chastanet, J De Vry, T Glaser, J Adrien and M HamonJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 920-929;
Glavin, G B
- You have accessSome novel 5-hydroxytryptamine1A (5-HT1A) receptor agonists reduce gastric acid and pepsin secretion, reduce experimental gastric mucosal injury and enhance gastric mucus in rats.A J Farré, M Colombo, I Alvarez and G B GlavinJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 832-837;
Goldberg, S R
- You have accessCalcium channel blockers antagonize some of cocaine's cardiovascular effects, but fail to alter cocaine's behavioral effects.C W Schindler, S R Tella, J Prada and S R GoldbergJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 791-798;
Gores, G J
- You have accessUrsodeoxycholate (UDCA) inhibits the mitochondrial membrane permeability transition induced by glycochenodeoxycholate: a mechanism of UDCA cytoprotection.R Botla, J R Spivey, H Aguilar, S F Bronk and G J GoresJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 930-938;
Grattagliano, I
- You have accessDisposition of glutathione monoethyl ester in the rat: glutathione ester is a slow release form of extracellular glutathione.I Grattagliano, P Wieland, C Schranz and B H LauterburgJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 484-488;
Greenwald, M K
- You have accessMarijuana smoking: effects of varying puff volume and breathhold duration.J L Azorlosa, M K Greenwald and M L StitzerJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 560-569;
Griffiths, R R
- You have accessAbecarnil and alprazolam in humans: behavioral, subjective and reinforcing effects.G K Mumford, C R Rush and R R GriffithsJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 570-580;
Grundström, N
- You have accessPertussis toxin attenuates presynaptic inhibition of cholinergic but not nonadrenergic noncholinergic contraction in guinea pig airways.I G Johansson-Rydberg, N Grundström and R G AnderssonJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 786-790;
Guenthner, T M
- You have accessMetabolism of allylbenzene 2',3'-oxide and estragole 2',3'-oxide in the isolated perfused rat liver.G Luo and T M GuenthnerJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 588-596;
H
Hamilton, B J
- You have access[4-Dimethyl-3-t-butylcarboxyl-4,5-dihydro (1,5-a) quinoxaline] is a novel ligand to the picrotoxin site on GABAA receptors, and decreases single-channel open probability.G H Dillon, W B Im, J F Pregenzer, D B Carter and B J HamiltonJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 597-603;
Hamon, M
- You have accessAre postsynaptic 5-HT1A receptors involved in the anxiolytic effects of 5-HT1A receptor agonists and in their inhibitory effects on the firing of serotonergic neurons in the rat?T Jolas, R Schreiber, A M Laporte, M Chastanet, J De Vry, T Glaser, J Adrien and M HamonJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 920-929;
Harris, R R
- You have accessOptimization of the potency and duration of action of N-hydroxyurea 5-lipoxygenase inhibitors.R L Bell, J B Bouska, P E Malo, C Lanni, R R Harris, E R Otis, A O Stewart, D W Brooks and G W CarterJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 724-731;
Hattler, B G
- You have accessNitric oxide synthase inhibitor alters papillary muscle force-frequency relationship.M S Finkel, C V Oddis, O H Mayer, B G Hattler and R L SimmonsJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 945-952;
Hayashi, M
- You have accessAbsorption-enhancing mechanism of sodium caprate and decanoylcarnitine in Caco-2 cells.M Tomita, M Hayashi and S AwazuJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 739-743;
Heldman, E
- You have accessLow doses of anandamides inhibit pharmacological effects of delta 9-tetrahydrocannabinol.E Fride, J Barg, R Levy, D Saya, E Heldman, R Mechoulam and Z VogelJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 699-707;
Hilditch, A
- You have accessPharmacological effects of GR138950, a novel angiotensin AT1 receptor antagonist.A Hilditch, A A Hunt, A Travers, J Polley, G M Drew, D Middlemiss, D B Judd, B C Ross and M J RobertsonJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 750-757;
Hiroi, T
- You have accessMepyramine, a histamine H1 receptor antagonist, inhibits the metabolic activity of rat and human P450 2D forms.T Hiroi, N Ohishi, S Imaoka, Y Yabusaki, H Fukui and Y FunaeJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 939-944;
Ho, A
- You have accessChronic administration of a cocaine "binge" alters basal extracellular levels in male rats: an in vivo microdialysis study.I M Maisonneuve, A Ho and M J KreekJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 652-657;
Hosseini, J M
- You have accessTherapeutic trial of reconstituted human high-density lipoprotein in a canine model of gram-negative septic shock.Z M Quezado, C Natanson, S M Banks, D W Alling, C A Koev, R L Danner, R J Elin, J M Hosseini, T S Parker and D M LevineJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 604-611;
Hoyano, Y
- You have accessSelective inhibition by zatebradine and discrete parasympathetic stimulation of the positive chronotropic response to sympathetic stimulation in anesthetized dogs.Y Furukawa, H Nakano, T Oguchi, M Kasama, Y Hoyano and S ChibaJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 744-749;
Hudson, A
- You have accessInhibition of amine oxidase activity by derivatives that recognize imidazoline I2 sites.C Carpéné, P Collon, A Remaury, A Cordi, A Hudson, D Nutt and M LafontanJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 681-688;
Hunt, A A
- You have accessPharmacological effects of GR138950, a novel angiotensin AT1 receptor antagonist.A Hilditch, A A Hunt, A Travers, J Polley, G M Drew, D Middlemiss, D B Judd, B C Ross and M J RobertsonJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 750-757;
I
Iga, T
- You have accessComparative analysis of buprenorphine- and norbuprenorphine-induced analgesic effects based on pharmacokinetic-pharmacodynamic modeling.M Ohtani, H Kotaki, Y Sawada and T IgaJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 505-510;
Ihara, Y
- You have accessAquaretic effect of a potent, orally active, nonpeptide V2 antagonist in men.A Ohnishi, Y Orita, N Takagi, T Fujita, T Toyoki, Y Ihara, Y Yamamura, T Inoue and T TanakaJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 546-551;
Im, W B
- You have access[4-Dimethyl-3-t-butylcarboxyl-4,5-dihydro (1,5-a) quinoxaline] is a novel ligand to the picrotoxin site on GABAA receptors, and decreases single-channel open probability.G H Dillon, W B Im, J F Pregenzer, D B Carter and B J HamiltonJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 597-603;
Imaoka, S
- You have accessMepyramine, a histamine H1 receptor antagonist, inhibits the metabolic activity of rat and human P450 2D forms.T Hiroi, N Ohishi, S Imaoka, Y Yabusaki, H Fukui and Y FunaeJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 939-944;
Inoue, T
- You have accessAquaretic effect of a potent, orally active, nonpeptide V2 antagonist in men.A Ohnishi, Y Orita, N Takagi, T Fujita, T Toyoki, Y Ihara, Y Yamamura, T Inoue and T TanakaJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 546-551;
J
Jackson, B
- You have accessSeparation of immunomodulatory and cholesterol-lowering activities of heterocyclic azaspiranes.C R Albrightson, P J Bugelski, T A Berkhout, B Jackson, W D Kerns, A J Organ and A M BadgerJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 689-698;
Jakubowski, J A
- You have accessIn vivo effects of a novel thromboxane A2/prostaglandin H2 (TXA2/PGH2) partial agonist, (+)5(Z)-7-[3-endo-phenylsulfonylamino[2.2.1]- bicyclohept-2-exo-yl]-heptenoic acid [(+)-S-145], on vascular, platelet and cardiac function.G P Dubé, J A Jakubowski, K A Brune, K G Bemis and W L KurtzJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 799-807;
Johansson-Rydberg, I G
- You have accessPertussis toxin attenuates presynaptic inhibition of cholinergic but not nonadrenergic noncholinergic contraction in guinea pig airways.I G Johansson-Rydberg, N Grundström and R G AnderssonJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 786-790;
Jolas, T
- You have accessAre postsynaptic 5-HT1A receptors involved in the anxiolytic effects of 5-HT1A receptor agonists and in their inhibitory effects on the firing of serotonergic neurons in the rat?T Jolas, R Schreiber, A M Laporte, M Chastanet, J De Vry, T Glaser, J Adrien and M HamonJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 920-929;
Judd, D B
- You have accessPharmacological effects of GR138950, a novel angiotensin AT1 receptor antagonist.A Hilditch, A A Hunt, A Travers, J Polley, G M Drew, D Middlemiss, D B Judd, B C Ross and M J RobertsonJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 750-757;
K
Kagitani, Y
- You have accessProtective effects of AE0047, a novel calcium antagonist, on incidence of stroke and hemodynamic disturbances in stroke-prone spontaneously hypertensive rats.H Shinyama, H Nagai, T Kawamura, Y Narita, T Uchida, M Watanabe and Y KagitaniJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 911-919;
Kasama, M
- You have accessSelective inhibition by zatebradine and discrete parasympathetic stimulation of the positive chronotropic response to sympathetic stimulation in anesthetized dogs.Y Furukawa, H Nakano, T Oguchi, M Kasama, Y Hoyano and S ChibaJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 744-749;
- You have accessAre negative chronotropic and inotropic responses to adenosine differentiated at the receptor or postreceptor levels in isolated dog hearts?T Oguchi, Y Furukawa, S Sawaki, M Kasama and S ChibaJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 838-844;
Kawamura, T
- You have accessProtective effects of AE0047, a novel calcium antagonist, on incidence of stroke and hemodynamic disturbances in stroke-prone spontaneously hypertensive rats.H Shinyama, H Nagai, T Kawamura, Y Narita, T Uchida, M Watanabe and Y KagitaniJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 911-919;
Kawase, Y
- You have accessSuppression of interleukin-1 alpha production by protein kinase C activators in human vascular endothelial cells.M Watanabe, Y Kawase, J Tanabe, K R Min, S Mue and K OhuchiJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 808-814;
Kerns, W D
- You have accessSeparation of immunomodulatory and cholesterol-lowering activities of heterocyclic azaspiranes.C R Albrightson, P J Bugelski, T A Berkhout, B Jackson, W D Kerns, A J Organ and A M BadgerJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 689-698;
Kirchengast, M
- You have accessPrevious exposure to bradykinin unmasks an endothelium-dependent relaxation to the converting enzyme inhibitor trandolaprilat in isolated canine coronary arteries.B Desta, M Nakashima, M Kirchengast, P M Vanhoutte and C M BoulangerJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 885-891;
Koev, C A
- You have accessTherapeutic trial of reconstituted human high-density lipoprotein in a canine model of gram-negative septic shock.Z M Quezado, C Natanson, S M Banks, D W Alling, C A Koev, R L Danner, R J Elin, J M Hosseini, T S Parker and D M LevineJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 604-611;
Koob, G F
- You have accessInterleukin-2 (IL-2) induces corticotropin-releasing factor (CRF) release from the amygdala and involves a nitric oxide-mediated signaling; comparison with the hypothalamic response.J Raber, G F Koob and F E BloomJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 815-824;
Kotaki, H
- You have accessComparative analysis of buprenorphine- and norbuprenorphine-induced analgesic effects based on pharmacokinetic-pharmacodynamic modeling.M Ohtani, H Kotaki, Y Sawada and T IgaJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 505-510;
Kreek, M J
- You have accessChronic administration of a cocaine "binge" alters basal extracellular levels in male rats: an in vivo microdialysis study.I M Maisonneuve, A Ho and M J KreekJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 652-657;
Kurtz, W L
- You have accessIn vivo effects of a novel thromboxane A2/prostaglandin H2 (TXA2/PGH2) partial agonist, (+)5(Z)-7-[3-endo-phenylsulfonylamino[2.2.1]- bicyclohept-2-exo-yl]-heptenoic acid [(+)-S-145], on vascular, platelet and cardiac function.G P Dubé, J A Jakubowski, K A Brune, K G Bemis and W L KurtzJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 799-807;
L
Lafontan, M
- You have accessInhibition of amine oxidase activity by derivatives that recognize imidazoline I2 sites.C Carpéné, P Collon, A Remaury, A Cordi, A Hudson, D Nutt and M LafontanJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 681-688;
Lambrecht, R W
- You have accessTissue distribution of zinc-mesoporphyrin in rats: relationship to inhibition of heme oxygenase.S M Russo, J A Pepe, S Donohue, E E Cable, R W Lambrecht and H L BonkovskyJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 766-774;
Lanni, C
- You have accessOptimization of the potency and duration of action of N-hydroxyurea 5-lipoxygenase inhibitors.R L Bell, J B Bouska, P E Malo, C Lanni, R R Harris, E R Otis, A O Stewart, D W Brooks and G W CarterJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 724-731;
Laorden, M L
- You have accessCross-tolerance between kappa and mu opioid agonists in the guinea pig ileum myenteric plexus.J V Garaulet, M V Milanés and M L LaordenJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 658-662;
Laporte, A M
- You have accessAre postsynaptic 5-HT1A receptors involved in the anxiolytic effects of 5-HT1A receptor agonists and in their inhibitory effects on the firing of serotonergic neurons in the rat?T Jolas, R Schreiber, A M Laporte, M Chastanet, J De Vry, T Glaser, J Adrien and M HamonJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 920-929;
Lauterburg, B H
- You have accessDisposition of glutathione monoethyl ester in the rat: glutathione ester is a slow release form of extracellular glutathione.I Grattagliano, P Wieland, C Schranz and B H LauterburgJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 484-488;
Levine, D M
- You have accessTherapeutic trial of reconstituted human high-density lipoprotein in a canine model of gram-negative septic shock.Z M Quezado, C Natanson, S M Banks, D W Alling, C A Koev, R L Danner, R J Elin, J M Hosseini, T S Parker and D M LevineJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 604-611;
Levy, R
- You have accessLow doses of anandamides inhibit pharmacological effects of delta 9-tetrahydrocannabinol.E Fride, J Barg, R Levy, D Saya, E Heldman, R Mechoulam and Z VogelJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 699-707;
Liebson, I A
- You have accessBuprenorphine effects in methadone-maintained volunteers: effects at two hours after methadone.E C Strain, K L Preston, I A Liebson and G E BigelowJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 628-638;
Linden, J
- You have accessComparison of A4 and A2a binding sites in striatum and COS cells transfected with adenosine A2a receptors.D R Luthin and J LindenJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 511-518;
Little, H J
- You have accessIdentification of distinct components, with different time courses, of the changes in response to convulsive stimuli during ethanol withdrawal.W P Watson and H J LittleJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 876-884;
Luo, G
- You have accessMetabolism of allylbenzene 2',3'-oxide and estragole 2',3'-oxide in the isolated perfused rat liver.G Luo and T M GuenthnerJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 588-596;
Luthin, D R
- You have accessComparison of A4 and A2a binding sites in striatum and COS cells transfected with adenosine A2a receptors.D R Luthin and J LindenJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 511-518;
Lysle, D T
- You have accessMechanisms whereby macrophage-derived nitric oxide is involved in morphine-induced suppression of splenic lymphocyte proliferation.K Fecho, K A Maslonek, L A Dykstra and D T LysleJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 477-483;
M
Madan, A
- You have accessCharacterization of diethyldithiocarbamate methyl ester sulfine as an intermediate in the bioactivation of disulfiram.A Madan and M D FaimanJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 775-780;
Maisonneuve, I M
- You have accessChronic administration of a cocaine "binge" alters basal extracellular levels in male rats: an in vivo microdialysis study.I M Maisonneuve, A Ho and M J KreekJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 652-657;
Malo, P E
- You have accessOptimization of the potency and duration of action of N-hydroxyurea 5-lipoxygenase inhibitors.R L Bell, J B Bouska, P E Malo, C Lanni, R R Harris, E R Otis, A O Stewart, D W Brooks and G W CarterJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 724-731;
Martel, J C
- You have accessContinuous administration decreases and pulsatile administration increases behavioral sensitivity to a novel dopamine D2 agonist (U-91356A) in MPTP-exposed monkeys.P J Blanchet, F Calon, J C Martel, P J Bédard, T Di Paolo, R R Walters and M F PierceyJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 854-859;
Maslonek, K A
- You have accessMechanisms whereby macrophage-derived nitric oxide is involved in morphine-induced suppression of splenic lymphocyte proliferation.K Fecho, K A Maslonek, L A Dykstra and D T LysleJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 477-483;
Mayer, O H
- You have accessNitric oxide synthase inhibitor alters papillary muscle force-frequency relationship.M S Finkel, C V Oddis, O H Mayer, B G Hattler and R L SimmonsJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 945-952;
Mechoulam, R
- You have accessLow doses of anandamides inhibit pharmacological effects of delta 9-tetrahydrocannabinol.E Fride, J Barg, R Levy, D Saya, E Heldman, R Mechoulam and Z VogelJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 699-707;
Middlemiss, D
- You have accessPharmacological effects of GR138950, a novel angiotensin AT1 receptor antagonist.A Hilditch, A A Hunt, A Travers, J Polley, G M Drew, D Middlemiss, D B Judd, B C Ross and M J RobertsonJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 750-757;
Milanés, M V
- You have accessCross-tolerance between kappa and mu opioid agonists in the guinea pig ileum myenteric plexus.J V Garaulet, M V Milanés and M L LaordenJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 658-662;
Min, K R
- You have accessSuppression of interleukin-1 alpha production by protein kinase C activators in human vascular endothelial cells.M Watanabe, Y Kawase, J Tanabe, K R Min, S Mue and K OhuchiJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 808-814;
Moerschbaecher, J M
- You have accessRepeated acquisition of behavioral chains in squirrel monkeys: comparisons of a mu, kappa and delta opioid agonist.E D Pakarinen, J H Woods and J M MoerschbaecherJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 552-559;
Mue, S
- You have accessSuppression of interleukin-1 alpha production by protein kinase C activators in human vascular endothelial cells.M Watanabe, Y Kawase, J Tanabe, K R Min, S Mue and K OhuchiJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 808-814;
Mullikin-Kilpatrick, D
- You have accessInhibition of dihydropyridine-sensitive Ca++ channels by ethanol in undifferentiated and nerve growth factor-treated PC12 cells: interaction with the inactivated state.D Mullikin-Kilpatrick and S N TreistmanJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 489-497;
Mumford, G K
- You have accessAbecarnil and alprazolam in humans: behavioral, subjective and reinforcing effects.G K Mumford, C R Rush and R R GriffithsJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 570-580;
Muntoni, A
- You have accessProfound decrease of mesolimbic dopaminergic neuronal activity in morphine withdrawn rats.M Diana, M Pistis, A Muntoni and G GessaJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 781-785;
Murray, M
- You have accessIdentification of a reversible component in the in vitro inhibition of rat hepatic cytochrome P450 2B1 by parathion.M Murray and A M ButlerJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 639-644;
N
Nagai, H
- You have accessProtective effects of AE0047, a novel calcium antagonist, on incidence of stroke and hemodynamic disturbances in stroke-prone spontaneously hypertensive rats.H Shinyama, H Nagai, T Kawamura, Y Narita, T Uchida, M Watanabe and Y KagitaniJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 911-919;
Nakano, H
- You have accessSelective inhibition by zatebradine and discrete parasympathetic stimulation of the positive chronotropic response to sympathetic stimulation in anesthetized dogs.Y Furukawa, H Nakano, T Oguchi, M Kasama, Y Hoyano and S ChibaJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 744-749;
Nakashima, M
- You have accessPrevious exposure to bradykinin unmasks an endothelium-dependent relaxation to the converting enzyme inhibitor trandolaprilat in isolated canine coronary arteries.B Desta, M Nakashima, M Kirchengast, P M Vanhoutte and C M BoulangerJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 885-891;
Narita, Y
- You have accessProtective effects of AE0047, a novel calcium antagonist, on incidence of stroke and hemodynamic disturbances in stroke-prone spontaneously hypertensive rats.H Shinyama, H Nagai, T Kawamura, Y Narita, T Uchida, M Watanabe and Y KagitaniJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 911-919;
Natanson, C
- You have accessTherapeutic trial of reconstituted human high-density lipoprotein in a canine model of gram-negative septic shock.Z M Quezado, C Natanson, S M Banks, D W Alling, C A Koev, R L Danner, R J Elin, J M Hosseini, T S Parker and D M LevineJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 604-611;
Nieves, A L
- You have accessCharacterization of a behavioral model for peripherally evoked itch suggests platelet-activating factor as a potent pruritogen.D F Woodward, A L Nieves, C S Spada, L S Williams and R P TuckettJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 758-765;
Nocerini, M R
- You have accessA novel quantitative method for determining the biodistribution of radiolabeled xenobiotics using whole-body cryosectioning and autoradioluminography.M J Potchoiba, T G Tensfeldt, M R Nocerini and B M SilberJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 953-962;
Nutt, D
- You have accessInhibition of amine oxidase activity by derivatives that recognize imidazoline I2 sites.C Carpéné, P Collon, A Remaury, A Cordi, A Hudson, D Nutt and M LafontanJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 681-688;
O
Oddis, C V
- You have accessNitric oxide synthase inhibitor alters papillary muscle force-frequency relationship.M S Finkel, C V Oddis, O H Mayer, B G Hattler and R L SimmonsJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 945-952;
Oguchi, T
- You have accessSelective inhibition by zatebradine and discrete parasympathetic stimulation of the positive chronotropic response to sympathetic stimulation in anesthetized dogs.Y Furukawa, H Nakano, T Oguchi, M Kasama, Y Hoyano and S ChibaJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 744-749;
- You have accessAre negative chronotropic and inotropic responses to adenosine differentiated at the receptor or postreceptor levels in isolated dog hearts?T Oguchi, Y Furukawa, S Sawaki, M Kasama and S ChibaJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 838-844;
Ohishi, N
- You have accessMepyramine, a histamine H1 receptor antagonist, inhibits the metabolic activity of rat and human P450 2D forms.T Hiroi, N Ohishi, S Imaoka, Y Yabusaki, H Fukui and Y FunaeJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 939-944;
Ohnishi, A
- You have accessAquaretic effect of a potent, orally active, nonpeptide V2 antagonist in men.A Ohnishi, Y Orita, N Takagi, T Fujita, T Toyoki, Y Ihara, Y Yamamura, T Inoue and T TanakaJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 546-551;
Ohtani, M
- You have accessComparative analysis of buprenorphine- and norbuprenorphine-induced analgesic effects based on pharmacokinetic-pharmacodynamic modeling.M Ohtani, H Kotaki, Y Sawada and T IgaJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 505-510;
Ohuchi, K
- You have accessSuppression of interleukin-1 alpha production by protein kinase C activators in human vascular endothelial cells.M Watanabe, Y Kawase, J Tanabe, K R Min, S Mue and K OhuchiJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 808-814;
Organ, A J
- You have accessSeparation of immunomodulatory and cholesterol-lowering activities of heterocyclic azaspiranes.C R Albrightson, P J Bugelski, T A Berkhout, B Jackson, W D Kerns, A J Organ and A M BadgerJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 689-698;
Orita, Y
- You have accessAquaretic effect of a potent, orally active, nonpeptide V2 antagonist in men.A Ohnishi, Y Orita, N Takagi, T Fujita, T Toyoki, Y Ihara, Y Yamamura, T Inoue and T TanakaJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 546-551;
Orzi, F
- You have accessEffects of acute and delayed effects of prior chronic cocaine administration on regional rates of cerebral protein synthesis in rats.F Orzi, Y Sun, K Pettigrew, L Sokoloff and C B SmithJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 892-900;
Otis, E R
- You have accessOptimization of the potency and duration of action of N-hydroxyurea 5-lipoxygenase inhibitors.R L Bell, J B Bouska, P E Malo, C Lanni, R R Harris, E R Otis, A O Stewart, D W Brooks and G W CarterJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 724-731;
P
Pakarinen, E D
- You have accessRepeated acquisition of behavioral chains in squirrel monkeys: comparisons of a mu, kappa and delta opioid agonist.E D Pakarinen, J H Woods and J M MoerschbaecherJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 552-559;
Panchal, B C
- You have accessRepression of angiotensin II and potentiation of bradykinin contribute to the synergistic effects of dual metalloprotease inhibition in heart failure.N C Trippodo, B C Panchal and M FoxJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 619-627;
Parker, T S
- You have accessTherapeutic trial of reconstituted human high-density lipoprotein in a canine model of gram-negative septic shock.Z M Quezado, C Natanson, S M Banks, D W Alling, C A Koev, R L Danner, R J Elin, J M Hosseini, T S Parker and D M LevineJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 604-611;
Pepe, J A
- You have accessTissue distribution of zinc-mesoporphyrin in rats: relationship to inhibition of heme oxygenase.S M Russo, J A Pepe, S Donohue, E E Cable, R W Lambrecht and H L BonkovskyJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 766-774;
Perrault, G
- You have accessEffects of typical and atypical antipsychotic drugs on response decrement patterns in rats.D J Sanger and G PerraultJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 708-713;
Pettigrew, K
- You have accessEffects of acute and delayed effects of prior chronic cocaine administration on regional rates of cerebral protein synthesis in rats.F Orzi, Y Sun, K Pettigrew, L Sokoloff and C B SmithJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 892-900;
Piercey, M F
- You have accessContinuous administration decreases and pulsatile administration increases behavioral sensitivity to a novel dopamine D2 agonist (U-91356A) in MPTP-exposed monkeys.P J Blanchet, F Calon, J C Martel, P J Bédard, T Di Paolo, R R Walters and M F PierceyJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 854-859;
Piletz, J E
- You have accessComparison of the properties of agmatine and endogenous clonidine-displacing substance at imidazoline and alpha-2 adrenergic receptors.J E Piletz, D N Chikkala and P ErnsbergerJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 581-587;
Pistis, M
- You have accessProfound decrease of mesolimbic dopaminergic neuronal activity in morphine withdrawn rats.M Diana, M Pistis, A Muntoni and G GessaJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 781-785;
Polley, J
- You have accessPharmacological effects of GR138950, a novel angiotensin AT1 receptor antagonist.A Hilditch, A A Hunt, A Travers, J Polley, G M Drew, D Middlemiss, D B Judd, B C Ross and M J RobertsonJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 750-757;
Porrino, L J
- You have accessBehavioral and local cerebral metabolic effects of the novel tropane analog, 2 beta-propanoyl-3 beta-(4-tolyl)-tropane.L J Porrino, H M Davies and S R ChildersJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 901-910;
Potchoiba, M J
- You have accessA novel quantitative method for determining the biodistribution of radiolabeled xenobiotics using whole-body cryosectioning and autoradioluminography.M J Potchoiba, T G Tensfeldt, M R Nocerini and B M SilberJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 953-962;
Prada, J
- You have accessCalcium channel blockers antagonize some of cocaine's cardiovascular effects, but fail to alter cocaine's behavioral effects.C W Schindler, S R Tella, J Prada and S R GoldbergJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 791-798;
Pregenzer, J F
- You have access[4-Dimethyl-3-t-butylcarboxyl-4,5-dihydro (1,5-a) quinoxaline] is a novel ligand to the picrotoxin site on GABAA receptors, and decreases single-channel open probability.G H Dillon, W B Im, J F Pregenzer, D B Carter and B J HamiltonJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 597-603;
Preston, K L
- You have accessBuprenorphine effects in methadone-maintained volunteers: effects at two hours after methadone.E C Strain, K L Preston, I A Liebson and G E BigelowJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 628-638;
Q
Quezado, Z M
- You have accessTherapeutic trial of reconstituted human high-density lipoprotein in a canine model of gram-negative septic shock.Z M Quezado, C Natanson, S M Banks, D W Alling, C A Koev, R L Danner, R J Elin, J M Hosseini, T S Parker and D M LevineJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 604-611;
Quirion, R
- You have accessCharacterization of neuropeptide Y binding sites in rat brain membrane preparations using [125I][Leu31,Pro34]peptide YY and [125I]peptide YY3-36 as selective Y1 and Y2 radioligands.Y Dumont, A Fournier, S St-Pierre and R QuirionJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 673-680;
R
Raber, J
- You have accessInterleukin-2 (IL-2) induces corticotropin-releasing factor (CRF) release from the amygdala and involves a nitric oxide-mediated signaling; comparison with the hypothalamic response.J Raber, G F Koob and F E BloomJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 815-824;
Remaury, A
- You have accessInhibition of amine oxidase activity by derivatives that recognize imidazoline I2 sites.C Carpéné, P Collon, A Remaury, A Cordi, A Hudson, D Nutt and M LafontanJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 681-688;
Robertson, M J
- You have accessPharmacological effects of GR138950, a novel angiotensin AT1 receptor antagonist.A Hilditch, A A Hunt, A Travers, J Polley, G M Drew, D Middlemiss, D B Judd, B C Ross and M J RobertsonJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 750-757;
Ross, B C
- You have accessPharmacological effects of GR138950, a novel angiotensin AT1 receptor antagonist.A Hilditch, A A Hunt, A Travers, J Polley, G M Drew, D Middlemiss, D B Judd, B C Ross and M J RobertsonJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 750-757;
Rouveix, B
- You have accessEffects of morphine on the pathogenesis of murine Friend retrovirus infection.M L Veyries, M Sinet, B Desforges and B RouveixJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 498-504;
Rush, C R
- You have accessAbecarnil and alprazolam in humans: behavioral, subjective and reinforcing effects.G K Mumford, C R Rush and R R GriffithsJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 570-580;
Russo, S M
- You have accessTissue distribution of zinc-mesoporphyrin in rats: relationship to inhibition of heme oxygenase.S M Russo, J A Pepe, S Donohue, E E Cable, R W Lambrecht and H L BonkovskyJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 766-774;
S
Saeki, T
- You have accessA selective type V phosphodiesterase inhibitor, E4021, dilates porcine large coronary artery.T Saeki, H Adachi, Y Takase, S Yoshitake, S Souda and I SaitoJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 825-831;
Saito, I
- You have accessA selective type V phosphodiesterase inhibitor, E4021, dilates porcine large coronary artery.T Saeki, H Adachi, Y Takase, S Yoshitake, S Souda and I SaitoJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 825-831;
Sanger, D J
- You have accessEffects of typical and atypical antipsychotic drugs on response decrement patterns in rats.D J Sanger and G PerraultJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 708-713;
Sawada, Y
- You have accessComparative analysis of buprenorphine- and norbuprenorphine-induced analgesic effects based on pharmacokinetic-pharmacodynamic modeling.M Ohtani, H Kotaki, Y Sawada and T IgaJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 505-510;
Sawaki, S
- You have accessAre negative chronotropic and inotropic responses to adenosine differentiated at the receptor or postreceptor levels in isolated dog hearts?T Oguchi, Y Furukawa, S Sawaki, M Kasama and S ChibaJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 838-844;
Saya, D
- You have accessLow doses of anandamides inhibit pharmacological effects of delta 9-tetrahydrocannabinol.E Fride, J Barg, R Levy, D Saya, E Heldman, R Mechoulam and Z VogelJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 699-707;
Schindler, C W
- You have accessCalcium channel blockers antagonize some of cocaine's cardiovascular effects, but fail to alter cocaine's behavioral effects.C W Schindler, S R Tella, J Prada and S R GoldbergJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 791-798;
Schranz, C
- You have accessDisposition of glutathione monoethyl ester in the rat: glutathione ester is a slow release form of extracellular glutathione.I Grattagliano, P Wieland, C Schranz and B H LauterburgJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 484-488;
Schreiber, R
- You have accessAre postsynaptic 5-HT1A receptors involved in the anxiolytic effects of 5-HT1A receptor agonists and in their inhibitory effects on the firing of serotonergic neurons in the rat?T Jolas, R Schreiber, A M Laporte, M Chastanet, J De Vry, T Glaser, J Adrien and M HamonJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 920-929;
Seiden, L S
- You have accessRole of hypothermia in the mechanism of protection against serotonergic toxicity. I. Experiments using 3,4-methylenedioxymethamphetamine, dizocilpine, CGS 19755 and NBQX.G M Farfel and L S SeidenJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 860-867;
- You have accessRole of hypothermia in the mechanism of protection against serotonergic toxicity. II. Experiments with methamphetamine, p-chloroamphetamine, fenfluramine, dizocilpine and dextromethorphan.G M Farfel and L S SeidenJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 868-875;
Shinyama, H
- You have accessProtective effects of AE0047, a novel calcium antagonist, on incidence of stroke and hemodynamic disturbances in stroke-prone spontaneously hypertensive rats.H Shinyama, H Nagai, T Kawamura, Y Narita, T Uchida, M Watanabe and Y KagitaniJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 911-919;
Siegl, P K
- You have accessIn vivo receptor occupancy of the angiotensin II receptor by nonpeptide antagonists: relationship to in vitro affinities and in vivo pharmacologic potency.H T Beauchamp, R S Chang, P K Siegl and R E GibsonJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 612-618;
Silber, B M
- You have accessA novel quantitative method for determining the biodistribution of radiolabeled xenobiotics using whole-body cryosectioning and autoradioluminography.M J Potchoiba, T G Tensfeldt, M R Nocerini and B M SilberJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 953-962;
Simmons, R L
- You have accessNitric oxide synthase inhibitor alters papillary muscle force-frequency relationship.M S Finkel, C V Oddis, O H Mayer, B G Hattler and R L SimmonsJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 945-952;
Sinet, M
- You have accessEffects of morphine on the pathogenesis of murine Friend retrovirus infection.M L Veyries, M Sinet, B Desforges and B RouveixJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 498-504;
Smith, C B
- You have accessEffects of acute and delayed effects of prior chronic cocaine administration on regional rates of cerebral protein synthesis in rats.F Orzi, Y Sun, K Pettigrew, L Sokoloff and C B SmithJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 892-900;
Sokoloff, L
- You have accessEffects of acute and delayed effects of prior chronic cocaine administration on regional rates of cerebral protein synthesis in rats.F Orzi, Y Sun, K Pettigrew, L Sokoloff and C B SmithJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 892-900;
Souda, S
- You have accessA selective type V phosphodiesterase inhibitor, E4021, dilates porcine large coronary artery.T Saeki, H Adachi, Y Takase, S Yoshitake, S Souda and I SaitoJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 825-831;
Spada, C S
- You have accessCharacterization of a behavioral model for peripherally evoked itch suggests platelet-activating factor as a potent pruritogen.D F Woodward, A L Nieves, C S Spada, L S Williams and R P TuckettJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 758-765;
Spinelli, W
- You have accessVoltage-dependent inhibition of the ATP-sensitive K+ current by the class Ia agent disopyramide in cat ventricular myocytes.F G de Lorenzi, T R Bridal and W SpinelliJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 714-723;
Spitsbergen, J M
- You have accessThe paralytic agent 2,4-dithiobiuret decreases open time of murine skeletal muscle acetylcholine receptor channels.J M Spitsbergen and W D AtchisonJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 645-651;
Spivey, J R
- You have accessUrsodeoxycholate (UDCA) inhibits the mitochondrial membrane permeability transition induced by glycochenodeoxycholate: a mechanism of UDCA cytoprotection.R Botla, J R Spivey, H Aguilar, S F Bronk and G J GoresJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 930-938;
St-Pierre, S
- You have accessCharacterization of neuropeptide Y binding sites in rat brain membrane preparations using [125I][Leu31,Pro34]peptide YY and [125I]peptide YY3-36 as selective Y1 and Y2 radioligands.Y Dumont, A Fournier, S St-Pierre and R QuirionJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 673-680;
Stewart, A O
- You have accessOptimization of the potency and duration of action of N-hydroxyurea 5-lipoxygenase inhibitors.R L Bell, J B Bouska, P E Malo, C Lanni, R R Harris, E R Otis, A O Stewart, D W Brooks and G W CarterJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 724-731;
Stitzer, M L
- You have accessMarijuana smoking: effects of varying puff volume and breathhold duration.J L Azorlosa, M K Greenwald and M L StitzerJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 560-569;
Strain, E C
- You have accessBuprenorphine effects in methadone-maintained volunteers: effects at two hours after methadone.E C Strain, K L Preston, I A Liebson and G E BigelowJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 628-638;
Sun, Y
- You have accessEffects of acute and delayed effects of prior chronic cocaine administration on regional rates of cerebral protein synthesis in rats.F Orzi, Y Sun, K Pettigrew, L Sokoloff and C B SmithJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 892-900;
T
Takagi, N
- You have accessAquaretic effect of a potent, orally active, nonpeptide V2 antagonist in men.A Ohnishi, Y Orita, N Takagi, T Fujita, T Toyoki, Y Ihara, Y Yamamura, T Inoue and T TanakaJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 546-551;
Takase, Y
- You have accessA selective type V phosphodiesterase inhibitor, E4021, dilates porcine large coronary artery.T Saeki, H Adachi, Y Takase, S Yoshitake, S Souda and I SaitoJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 825-831;
Tanabe, J
- You have accessSuppression of interleukin-1 alpha production by protein kinase C activators in human vascular endothelial cells.M Watanabe, Y Kawase, J Tanabe, K R Min, S Mue and K OhuchiJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 808-814;
Tanaka, T
- You have accessAquaretic effect of a potent, orally active, nonpeptide V2 antagonist in men.A Ohnishi, Y Orita, N Takagi, T Fujita, T Toyoki, Y Ihara, Y Yamamura, T Inoue and T TanakaJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 546-551;
Tella, S R
- You have accessCalcium channel blockers antagonize some of cocaine's cardiovascular effects, but fail to alter cocaine's behavioral effects.C W Schindler, S R Tella, J Prada and S R GoldbergJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 791-798;
Tensfeldt, T G
- You have accessA novel quantitative method for determining the biodistribution of radiolabeled xenobiotics using whole-body cryosectioning and autoradioluminography.M J Potchoiba, T G Tensfeldt, M R Nocerini and B M SilberJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 953-962;
Tomita, M
- You have accessAbsorption-enhancing mechanism of sodium caprate and decanoylcarnitine in Caco-2 cells.M Tomita, M Hayashi and S AwazuJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 739-743;
Toyoki, T
- You have accessAquaretic effect of a potent, orally active, nonpeptide V2 antagonist in men.A Ohnishi, Y Orita, N Takagi, T Fujita, T Toyoki, Y Ihara, Y Yamamura, T Inoue and T TanakaJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 546-551;
Travers, A
- You have accessPharmacological effects of GR138950, a novel angiotensin AT1 receptor antagonist.A Hilditch, A A Hunt, A Travers, J Polley, G M Drew, D Middlemiss, D B Judd, B C Ross and M J RobertsonJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 750-757;
Treistman, S N
- You have accessInhibition of dihydropyridine-sensitive Ca++ channels by ethanol in undifferentiated and nerve growth factor-treated PC12 cells: interaction with the inactivated state.D Mullikin-Kilpatrick and S N TreistmanJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 489-497;
Trippodo, N C
- You have accessRepression of angiotensin II and potentiation of bradykinin contribute to the synergistic effects of dual metalloprotease inhibition in heart failure.N C Trippodo, B C Panchal and M FoxJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 619-627;
Tuckett, R P
- You have accessCharacterization of a behavioral model for peripherally evoked itch suggests platelet-activating factor as a potent pruritogen.D F Woodward, A L Nieves, C S Spada, L S Williams and R P TuckettJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 758-765;
U
Uchida, T
- You have accessProtective effects of AE0047, a novel calcium antagonist, on incidence of stroke and hemodynamic disturbances in stroke-prone spontaneously hypertensive rats.H Shinyama, H Nagai, T Kawamura, Y Narita, T Uchida, M Watanabe and Y KagitaniJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 911-919;
V
Vanhoutte, P M
- You have accessPrevious exposure to bradykinin unmasks an endothelium-dependent relaxation to the converting enzyme inhibitor trandolaprilat in isolated canine coronary arteries.B Desta, M Nakashima, M Kirchengast, P M Vanhoutte and C M BoulangerJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 885-891;
Veyries, M L
- You have accessEffects of morphine on the pathogenesis of murine Friend retrovirus infection.M L Veyries, M Sinet, B Desforges and B RouveixJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 498-504;
Vogel, Z
- You have accessLow doses of anandamides inhibit pharmacological effects of delta 9-tetrahydrocannabinol.E Fride, J Barg, R Levy, D Saya, E Heldman, R Mechoulam and Z VogelJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 699-707;
W
Walters, R R
- You have accessContinuous administration decreases and pulsatile administration increases behavioral sensitivity to a novel dopamine D2 agonist (U-91356A) in MPTP-exposed monkeys.P J Blanchet, F Calon, J C Martel, P J Bédard, T Di Paolo, R R Walters and M F PierceyJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 854-859;
Watanabe, M
- You have accessSuppression of interleukin-1 alpha production by protein kinase C activators in human vascular endothelial cells.M Watanabe, Y Kawase, J Tanabe, K R Min, S Mue and K OhuchiJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 808-814;
- You have accessProtective effects of AE0047, a novel calcium antagonist, on incidence of stroke and hemodynamic disturbances in stroke-prone spontaneously hypertensive rats.H Shinyama, H Nagai, T Kawamura, Y Narita, T Uchida, M Watanabe and Y KagitaniJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 911-919;
Watson, W P
- You have accessIdentification of distinct components, with different time courses, of the changes in response to convulsive stimuli during ethanol withdrawal.W P Watson and H J LittleJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 876-884;
Wieland, P
- You have accessDisposition of glutathione monoethyl ester in the rat: glutathione ester is a slow release form of extracellular glutathione.I Grattagliano, P Wieland, C Schranz and B H LauterburgJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 484-488;
Williams, L S
- You have accessCharacterization of a behavioral model for peripherally evoked itch suggests platelet-activating factor as a potent pruritogen.D F Woodward, A L Nieves, C S Spada, L S Williams and R P TuckettJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 758-765;
Winger, G
- You have accessButorphanol: characterization of agonist and antagonist effects in rhesus monkeys.E R Butelman, G Winger, G Zernig and J H WoodsJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 845-853;
Woods, J H
- You have accessRepeated acquisition of behavioral chains in squirrel monkeys: comparisons of a mu, kappa and delta opioid agonist.E D Pakarinen, J H Woods and J M MoerschbaecherJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 552-559;
- You have accessButorphanol: characterization of agonist and antagonist effects in rhesus monkeys.E R Butelman, G Winger, G Zernig and J H WoodsJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 845-853;
Woodward, D F
- You have accessCharacterization of a behavioral model for peripherally evoked itch suggests platelet-activating factor as a potent pruritogen.D F Woodward, A L Nieves, C S Spada, L S Williams and R P TuckettJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 758-765;
Wright, S H
- You have accessKinetics of interactions of para-aminohippurate, probenecid, cysteine conjugates and N-acetyl cysteine conjugates with basolateral organic anion transporter in isolated rabbit proximal renal tubules.W H Dantzler, K K Evans and S H WrightJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 663-672;
Y
Yabusaki, Y
- You have accessMepyramine, a histamine H1 receptor antagonist, inhibits the metabolic activity of rat and human P450 2D forms.T Hiroi, N Ohishi, S Imaoka, Y Yabusaki, H Fukui and Y FunaeJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 939-944;
Yamamura, Y
- You have accessAquaretic effect of a potent, orally active, nonpeptide V2 antagonist in men.A Ohnishi, Y Orita, N Takagi, T Fujita, T Toyoki, Y Ihara, Y Yamamura, T Inoue and T TanakaJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 546-551;
Yoshitake, S
- You have accessA selective type V phosphodiesterase inhibitor, E4021, dilates porcine large coronary artery.T Saeki, H Adachi, Y Takase, S Yoshitake, S Souda and I SaitoJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 825-831;
Z
Zernig, G
- You have accessButorphanol: characterization of agonist and antagonist effects in rhesus monkeys.E R Butelman, G Winger, G Zernig and J H WoodsJournal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 845-853;
In this issue

Advertisement